samedan logo
 
 
spacer
home > pmps > winter 2021 > vaccine logistics: deep-freeze storage in container design
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Vaccine Logistics: Deep-Freeze Storage in Container Design

How Do You Transport and Store Vaccines Reliably at Temperatures of -70°C to -80°C?

L&R Kältetechnik has developed a coherent, efficient, and innovative concept for this challenge: a deepfreeze storage system that is installed in an industrial container. The basis for the development is the comprehensive knowledge L&R has acquired for the planning and manufacturing of sophisticated (deep) freeze systems and ultra-low temperature storage systems for pharmaceutical production.

Originally, the ‘core business’ for L&R Kältetechnik in the pharma industry was to provide the low temperatures required for production. Many production sites all over Europe are equipped with L&R cooling systems that can reach a cooling capacity in the megawatt (MW) range, and are absolutely fail-safe thanks to redundant refrigerating circuits.

Process Cooling For Pharma Production – Even in a Multi-Megawatt Range

One current example: L&R planned and installed a large cooling facility providing low temperatures on two levels of -15°C and -25°C for a manufacturer of medicines for the treatment of blood diseases such as haemophilia – and on a large scale at that. A total of five ultra-low temperature systems with 12 refrigerating circuits and a total cooling capacity of 2.35MW generate the required process cooling.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
L&R Kältetechnik GmbH & Co.

KG Hachenerstrasse 90a-c 59846 Sundern

www.lr-kaelte.de

E: info@lr-kaelte.de

Read more on L&R’s mobile pharma storage: https://bit. ly/3adrqfN
Print this page
Send to a friend
Privacy statement
News and Press Releases

Bio-Rad Launches Its CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics

HERCULES, Calif.–October 21, 2021–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX™ Opus 96 Dx System and the CFX™ Opus 384 Dx System
More info >>

White Papers
 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement